<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="cause" type="rst"/>
			<rel name="evidence" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="joint" type="multinuc"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="span">Frederick Frank</segment>
<segment id="2" parent="1" relname="elaboration">( businessman )</segment>
<segment id="3" parent="1005" relname="span">Frederick Frank</segment>
<segment id="4" parent="3" relname="elaboration">( born May 31 , 1932 , Salt Lake City , Utah )</segment>
<segment id="5" parent="1004" relname="same_unit">is an investment banker , with more than 50 years of experience on Wall Street .</segment>
<segment id="6" parent="1009" relname="span">He is considered the first investment banker</segment>
<segment id="7" parent="6" relname="elaboration">to have specialized in the areas of biotechnology , pharmaceuticals , and health care services .</segment>
<segment id="8" parent="1009" relname="evidence">[ 4 ]</segment>
<segment id="9" parent="1008" relname="evidence">[ 5 ]</segment>
<segment id="10" parent="1011" relname="preparation">As of 2014 , Frank became a founder and chair of EVOLUTION Life Science Partners .</segment>
<segment id="11" parent="1012" relname="span">He previously served as vice chairman of Lehman Brothers , Barclays Capital , and the Peter J. Solomon Company .</segment>
<segment id="12" parent="11" relname="evidence">[ 4 ]</segment>
<segment id="13" parent="1014" relname="span">He is credited as lead underwriter for over 125 IPOs and as a negotiator in over 75 mergers and acquisitions .</segment>
<segment id="14" parent="13" relname="evidence">[ 6 ]</segment>
<segment id="15" parent="1017" relname="span">Frank was chosen as one of the top 100 contributors to biotechnology in 2005 .</segment>
<segment id="16" parent="15" relname="evidence">[ 5 ]</segment>
<segment id="17" parent="1017" relname="evidence">[ 7 ]</segment>
<segment id="18" parent="1019" relname="preparation">Early life and education</segment>
<segment id="19" parent="1021" relname="span">Frederick Frank was born on May 31 , 1932 ,</segment>
<segment id="20" parent="19" relname="evidence">[ 8 ]</segment>
<segment id="21" parent="1022" relname="span">to Simon Frank and Suzanne</segment>
<segment id="22" parent="21" relname="elaboration">( Seller ) Frank of Salt Lake City , Utah .</segment>
<segment id="23" parent="1025" relname="span">He ran a men 's wear business</segment>
<segment id="24" parent="23" relname="elaboration">established by his father , Arthur Frank .</segment>
<segment id="25" parent="1025" relname="evidence">[ 9 ]</segment>
<segment id="26" parent="1028" relname="span">He completed high school at Hotchkiss School in Lakeville , Connecticut in 1950 .</segment>
<segment id="27" parent="1029" relname="joint">[ 8 ]</segment>
<segment id="28" parent="1029" relname="joint">[ 10 ]</segment>
<segment id="29" parent="1028" relname="evidence">[ 3 ]</segment>
<segment id="30" parent="1031" relname="span">Frank graduated in the class of 1954 from Yale University with a degree in philosophy .</segment>
<segment id="31" parent="30" relname="evidence">[ 11 ]</segment>
<segment id="32" parent="1019" relname="sequence">He served in the U.S. Army in Europe from 1954-1956 ,</segment>
<segment id="33" parent="1035" relname="span">much of the time in Paris , France at Supreme Headquarters Allied Powers Europe</segment>
<segment id="34" parent="33" relname="elaboration">( SHAPE ) .</segment>
<segment id="35" parent="1035" relname="evidence">[ 8 ]</segment>
<segment id="36" parent="37" relname="circumstance">After returning to the United States ,</segment>
<segment id="37" parent="1037" relname="span">he received an MBA from Stanford Graduate School of Business in 1958 .</segment>
<segment id="38" parent="1038" relname="joint">[ 10 ]</segment>
<segment id="39" parent="1038" relname="joint">[ 12 ]</segment>
<segment id="40" parent="1040" relname="preparation">Career</segment>
<segment id="41" parent="1040" relname="joint">In 1958 , Frank joined Smith , Barney and Company .</segment>
<segment id="42" parent="1042" relname="span">He chose to accept their offer</segment>
<segment id="43" parent="42" relname="cause">because they had a highly ranked research department .</segment>
<segment id="44" parent="1046" relname="circumstance">After completing the required formal training program ,</segment>
<segment id="45" parent="1046" relname="span">Frank joined the research department</segment>
<segment id="46" parent="45" relname="purpose">to work with Bill Grant on the pharmaceutical and chemical industries .</segment>
<segment id="47" parent="1043" relname="sequence">He soon proposed splitting the two areas ,</segment>
<segment id="48" parent="1049" relname="span">and became Wall Street â€™s first industry analyst</segment>
<segment id="49" parent="48" relname="elaboration">dedicated to pharmaceuticals .</segment>
<segment id="50" parent="1052" relname="span">In 1962 , he shifted focus to the life sciences industries ,</segment>
<segment id="51" parent="50" relname="elaboration">dealing with medical devices , diagnostics companies , and healthcare services .</segment>
<segment id="52" parent="1052" relname="evidence">[ 12 ]</segment>
<segment id="53" parent="1054" relname="span">He held the positions of co-leader of research , vice president , and director at Smith , Barney .</segment>
<segment id="54" parent="53" relname="evidence">[ 5 ]</segment>
<segment id="55" parent="1054" relname="evidence">[ 12 ]</segment>
<segment id="56" parent="1056" relname="joint">In October 1969 , Frank left Smith Barney</segment>
<segment id="57" parent="1057" relname="span">and joined Lehman Brothers , the first person from outside the organization</segment>
<segment id="58" parent="57" relname="purpose">to join it at the level of partner .</segment>
<segment id="59" parent="1059" relname="preparation">Leaving research and analysis ,</segment>
<segment id="60" parent="1060" relname="span">he shifted to investment banking ,</segment>
<segment id="61" parent="60" relname="elaboration">handling capital investment and mergers and acquisitions .</segment>
<segment id="62" parent="1063" relname="span">Frank is credited with creating original and at times unprecedented structures</segment>
<segment id="63" parent="62" relname="elaboration">that have connected innovative early-stage research-oriented companies with larger development and market-oriented pharmaceutical corporations .</segment>
<segment id="64" parent="1063" relname="evidence">[ 12 ]</segment>
<segment id="65" parent="1065" relname="span">In 1978 , Frank led a team at Lehman Brothers ,</segment>
<segment id="66" parent="65" relname="elaboration">handling Humana 's acquisition of American Medicorp .</segment>
<segment id="67" parent="1067" relname="span">The team included Mary Catherine Tanner , a recent graduate from Harvard University .</segment>
<segment id="68" parent="67" relname="evidence">[ 12 ]</segment>
<segment id="69" parent="1069" relname="sequence">Frank convinced her to join his team at Lehman .</segment>
<segment id="70" parent="1070" relname="span">Ten years later , on October 15 , 1988 , they were married .</segment>
<segment id="71" parent="70" relname="evidence">[ 3 ]</segment>
<segment id="72" parent="1072" relname="span">Frank became vice chair of Lehman Brothers in 1995 .</segment>
<segment id="73" parent="72" relname="evidence">[ 11 ]</segment>
<segment id="74" parent="1074" relname="span">Tanner became senior managing director .</segment>
<segment id="75" parent="74" relname="evidence">[ 1 ]</segment>
<segment id="76" parent="1077" relname="span">Frank and Tanner worked together at Lehman for over ten years ,</segment>
<segment id="77" parent="1078" relname="span">until Tanner took time off</segment>
<segment id="78" parent="77" relname="purpose">to have a child .</segment>
<segment id="79" parent="1077" relname="evidence">[ 2 ]</segment>
<segment id="80" parent="1080" relname="span">In the late 1970s , Frank began to work with companies such as Cetus , a company</segment>
<segment id="81" parent="80" relname="elaboration">developing industrial applications for Recombinant DNA technology , and Genentech .</segment>
<segment id="82" parent="1083" relname="span">Frank saw rDNA technology as a " game-changing opportunity " .</segment>
<segment id="83" parent="82" relname="evidence">[ 12 ]</segment>
<segment id="84" parent="1084" relname="sequence">Advised by Frank ,</segment>
<segment id="85" parent="1085" relname="span">Cetus went public on March 1 , 1981 with the second-largest IPO in U.S. corporate history .</segment>
<segment id="86" parent="85" relname="evidence">[ 12 ]</segment>
<segment id="87" parent="1087" relname="span">Frank was also instrumental in the Bristol-Myers Squibb merger of 1989 and the Hoffmann-La Roche acquisition of Genentech in 1990 .</segment>
<segment id="88" parent="87" relname="evidence">[ 12 ]</segment>
<segment id="89" parent="1066" relname="joint">At the time , the merger of an established pharmaceutical company with a younger biotechnology company was highly unusual .</segment>
<segment id="90" parent="1090" relname="span">It has been described by Frank as a " strategy of convergence " .</segment>
<segment id="91" parent="90" relname="evidence">[ 13 ]</segment>
<segment id="92" parent="1092" relname="span">After Barclays Capital bought Lehman 's U.S. capital markets unit in September 2008 ,</segment>
<segment id="93" parent="1093" relname="joint">[ 14 ]</segment>
<segment id="94" parent="1093" relname="joint">[ 15 ]</segment>
<segment id="95" parent="1095" relname="span">Frank became a vice chair at Barclays Capital .</segment>
<segment id="96" parent="95" relname="evidence">[ 16 ]</segment>
<segment id="97" parent="1097" relname="span">As of March 18 , 2009 , Frederick Frank and Mary Tanner joined Peter J. Solomon , of PJ SOLOMON</segment>
<segment id="98" parent="1099" relname="span">to form a new practice</segment>
<segment id="99" parent="98" relname="elaboration">focusing on pharmaceuticals and life sciences .</segment>
<segment id="100" parent="1099" relname="evidence">[ 16 ]</segment>
<segment id="101" parent="1101" relname="preparation">Frank became a vice chairman at Peter J. Solomon ,</segment>
<segment id="102" parent="1102" relname="span">while Tanner became a managing director .</segment>
<segment id="103" parent="102" relname="evidence">[ 17 ]</segment>
<segment id="104" parent="1104" relname="span">As of January 15 , 2013 , Frederick Frank and Mary Tanner joined Burrill &amp; Company .</segment>
<segment id="105" parent="104" relname="evidence">[ 18 ]</segment>
<segment id="106" parent="1108" relname="span">Frank became chair of Burrill Securities</segment>
<segment id="107" parent="106" relname="elaboration">( 2013- )</segment>
<segment id="108" parent="1109" relname="span">and vice chair of Burrill and Company</segment>
<segment id="109" parent="108" relname="elaboration">( January 15 , 2013- ) .</segment>
<segment id="110" parent="1107" relname="evidence">[ 19 ]</segment>
<segment id="111" parent="1111" relname="span">Tanner became the Senior Managing Director of Burrill Securities and of Burrill &amp; Company .</segment>
<segment id="112" parent="111" relname="evidence">[ 18 ]</segment>
<segment id="113" parent="1114" relname="sequence">As of 2014 , Frank and Tanner founded EVOLUTION Life Science Partners ,</segment>
<segment id="114" parent="1115" relname="span">and Frank became chair of the company .</segment>
<segment id="115" parent="114" relname="evidence">[ 4 ]</segment>
<segment id="116" parent="1116" relname="span">Frank has also served on numerous advisory groups and boards of directors .</segment>
<segment id="117" parent="116" relname="evidence">[ 19 ]</segment>
<segment id="118" parent="1118" relname="preparation">Philanthropy</segment>
<segment id="119" parent="1119" relname="span">As of October , 1997 , the non-profit Tanner Frank Foundation of New York City was granted charitable status .</segment>
<segment id="120" parent="119" relname="evidence">[ 20 ]</segment>
<segment id="121" parent="1123" relname="span">Frank has served on the board of advisors of the School of Management</segment>
<segment id="122" parent="121" relname="restatement">( SOM )</segment>
<segment id="123" parent="1122" relname="same_unit">at Yale University ,</segment>
<segment id="124" parent="1120" relname="sequence">and has given generously to SOM .</segment>
<segment id="125" parent="1125" relname="preparation">Gifts include the establishment of a language study fellowship and a visiting professorship in 1998 .</segment>
<segment id="126" parent="1126" relname="span">In 2007 , he established a professorship ,</segment>
<segment id="127" parent="126" relname="evidence">[ 11 ]</segment>
<segment id="128" parent="1128" relname="span">which was first filled in 2009</segment>
<segment id="129" parent="1129" relname="span">when Gary Gorton became Yale 's first Frederick Frank Class of 1954 Professor of Management and Finance .</segment>
<segment id="130" parent="129" relname="evidence">[ 21 ]</segment>
<segment id="131" parent="1131" relname="span">On April 9 , 2012 Olav Sorenson became the inaugural holder of the Frank and Tanner Professor of Management .</segment>
<segment id="132" parent="131" relname="evidence">[ 22 ]</segment>
<segment id="133" parent="1133" relname="preparation">Awards and honors</segment>
<segment id="134" parent="1134" relname="span">2019 , Richard J. Bolte Sr. Award for supporting industries</segment>
<segment id="135" parent="134" relname="evidence">[ 4 ]</segment>
<segment id="136" parent="1136" relname="span">2006 , Gilda 's Club of New York City Visionary Award</segment>
<segment id="137" parent="136" relname="evidence">[ 19 ]</segment>
<segment id="138" parent="1138" relname="span">2005 , Top 100 living contributors to biotechnology , Reed Elsevier</segment>
<segment id="139" parent="138" relname="evidence">[ 5 ]</segment>
<segment id="140" parent="1140" relname="span">2004 , Albert Einstein Award from the Weizmann Institute of Science</segment>
<segment id="141" parent="140" relname="evidence">[ 19 ]</segment>
<segment id="142" parent="1142" relname="span">1998 , Outstanding Contributions in the Field of Immunology , Irvington Institute for Immunological Research</segment>
<segment id="143" parent="1143" relname="joint">[ 19 ]</segment>
<segment id="144" parent="1143" relname="joint">[ 5 ]</segment>
<segment id="145" parent="1145" relname="span">1997 , Hall of Fame Award , The Biotech Meeting in Laguna Niguel , California .</segment>
<segment id="146" parent="145" relname="evidence">[ 5 ]</segment>
<segment id="147" parent="1145" relname="evidence">[ 6 ]</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1002" relname="preparation"/>
<group id="1002" type="multinuc" parent="1000" relname="span"/>
<group id="1003" type="multinuc" parent="1002" relname="joint"/>
<group id="1004" type="multinuc" parent="1003" relname="sequence"/>
<group id="1005" type="span" parent="1004" relname="same_unit"/>
<group id="1007" type="span" parent="1003" relname="sequence"/>
<group id="1008" type="span" parent="1007" relname="span"/>
<group id="1009" type="span" parent="1008" relname="span"/>
<group id="1010" type="span" parent="1003" relname="sequence"/>
<group id="1011" type="multinuc" parent="1010" relname="span"/>
<group id="1012" type="span" parent="1011" relname="sequence"/>
<group id="1014" type="span" parent="1011" relname="sequence"/>
<group id="1016" type="span" parent="1011" relname="sequence"/>
<group id="1017" type="span" parent="1016" relname="span"/>
<group id="1018" type="span" parent="1011" relname="sequence"/>
<group id="1019" type="multinuc" parent="1018" relname="span"/>
<group id="1020" type="multinuc" parent="1019" relname="sequence"/>
<group id="1021" type="span" parent="1020" relname="same_unit"/>
<group id="1022" type="span" parent="1020" relname="same_unit"/>
<group id="1024" type="span" parent="1019" relname="sequence"/>
<group id="1025" type="span" parent="1024" relname="span"/>
<group id="1027" type="span" parent="1019" relname="sequence"/>
<group id="1028" type="span" parent="1027" relname="span"/>
<group id="1029" type="multinuc" parent="26" relname="evidence"/>
<group id="1031" type="span" parent="1019" relname="sequence"/>
<group id="1034" type="span" parent="1019" relname="sequence"/>
<group id="1035" type="span" parent="1034" relname="span"/>
<group id="1036" type="span" parent="1019" relname="sequence"/>
<group id="1037" type="span" parent="1036" relname="span"/>
<group id="1038" type="multinuc" parent="1037" relname="evidence"/>
<group id="1039" type="span" parent="1002" relname="joint"/>
<group id="1040" type="multinuc" parent="1039" relname="span"/>
<group id="1042" type="span" parent="1040" relname="joint"/>
<group id="1043" type="multinuc" parent="1040" relname="joint"/>
<group id="1045" type="span" parent="1043" relname="sequence"/>
<group id="1046" type="span" parent="1045" relname="span"/>
<group id="1049" type="span" parent="1043" relname="sequence"/>
<group id="1051" type="span" parent="1043" relname="sequence"/>
<group id="1052" type="span" parent="1051" relname="span"/>
<group id="1053" type="span" parent="1043" relname="sequence"/>
<group id="1054" type="span" parent="1053" relname="span"/>
<group id="1056" type="multinuc" parent="1043" relname="sequence"/>
<group id="1057" type="span" parent="1056" relname="joint"/>
<group id="1058" type="span" parent="1043" relname="sequence"/>
<group id="1059" type="multinuc" parent="1058" relname="span"/>
<group id="1060" type="span" parent="1059" relname="joint"/>
<group id="1061" type="multinuc" parent="1059" relname="joint"/>
<group id="1062" type="span" parent="1061" relname="sequence"/>
<group id="1063" type="span" parent="1062" relname="span"/>
<group id="1065" type="span" parent="1061" relname="sequence"/>
<group id="1066" type="multinuc" parent="1061" relname="sequence"/>
<group id="1067" type="span" parent="1066" relname="joint"/>
<group id="1069" type="multinuc" parent="1066" relname="joint"/>
<group id="1070" type="span" parent="1069" relname="sequence"/>
<group id="1072" type="span" parent="1066" relname="joint"/>
<group id="1074" type="span" parent="1066" relname="joint"/>
<group id="1076" type="span" parent="1066" relname="joint"/>
<group id="1077" type="span" parent="1076" relname="span"/>
<group id="1078" type="span" parent="76" relname="circumstance"/>
<group id="1080" type="span" parent="1066" relname="joint"/>
<group id="1082" type="span" parent="1066" relname="joint"/>
<group id="1083" type="span" parent="1082" relname="span"/>
<group id="1084" type="multinuc" parent="1083" relname="elaboration"/>
<group id="1085" type="span" parent="1084" relname="sequence"/>
<group id="1087" type="span" parent="1066" relname="joint"/>
<group id="1090" type="span" parent="1066" relname="joint"/>
<group id="1091" type="multinuc" parent="1066" relname="joint"/>
<group id="1092" type="span" parent="1091" relname="sequence"/>
<group id="1093" type="multinuc" parent="92" relname="evidence"/>
<group id="1094" type="multinuc" parent="1091" relname="sequence"/>
<group id="1095" type="span" parent="1094" relname="joint"/>
<group id="1097" type="span" parent="1094" relname="joint"/>
<group id="1098" type="span" parent="97" relname="purpose"/>
<group id="1099" type="span" parent="1098" relname="span"/>
<group id="1100" type="span" parent="1094" relname="joint"/>
<group id="1101" type="multinuc" parent="1100" relname="span"/>
<group id="1102" type="span" parent="1101" relname="joint"/>
<group id="1104" type="span" parent="1101" relname="joint"/>
<group id="1106" type="span" parent="1101" relname="joint"/>
<group id="1107" type="multinuc" parent="1106" relname="span"/>
<group id="1108" type="span" parent="1107" relname="same_unit"/>
<group id="1109" type="span" parent="1107" relname="same_unit"/>
<group id="1111" type="span" parent="1101" relname="joint"/>
<group id="1114" type="multinuc" parent="1101" relname="joint"/>
<group id="1115" type="span" parent="1114" relname="sequence"/>
<group id="1116" type="span" parent="1101" relname="joint"/>
<group id="1117" type="span" parent="1101" relname="joint"/>
<group id="1118" type="multinuc" parent="1117" relname="span"/>
<group id="1119" type="span" parent="1118" relname="joint"/>
<group id="1120" type="multinuc" parent="1118" relname="joint"/>
<group id="1122" type="multinuc" parent="1120" relname="sequence"/>
<group id="1123" type="span" parent="1122" relname="same_unit"/>
<group id="1124" type="span" parent="1120" relname="sequence"/>
<group id="1125" type="multinuc" parent="1124" relname="span"/>
<group id="1126" type="span" parent="1125" relname="sequence"/>
<group id="1127" type="multinuc" parent="1125" relname="sequence"/>
<group id="1128" type="span" parent="1127" relname="joint"/>
<group id="1129" type="span" parent="128" relname="circumstance"/>
<group id="1131" type="span" parent="1127" relname="joint"/>
<group id="1132" type="span" parent="1127" relname="joint"/>
<group id="1133" type="multinuc" parent="1132" relname="span"/>
<group id="1134" type="span" parent="1133" relname="joint"/>
<group id="1136" type="span" parent="1133" relname="joint"/>
<group id="1138" type="span" parent="1133" relname="joint"/>
<group id="1140" type="span" parent="1133" relname="joint"/>
<group id="1142" type="span" parent="1133" relname="joint"/>
<group id="1143" type="multinuc" parent="142" relname="evidence"/>
<group id="1144" type="span" parent="1133" relname="joint"/>
<group id="1145" type="span" parent="1144" relname="span"/>
	</body>
</rst>
